Late Mortality in Childhood Cancer Survivors according to Pediatric Cancer Diagnosis and Treatment Era in the Dutch LATER Cohort

Cancer Invest. 2022 May;40(5):413-424. doi: 10.1080/07357907.2022.2034841. Epub 2022 Mar 7.

Abstract

This multi-center cohort-study examined late mortality among 6,165 Dutch five-year childhood cancer survivors diagnosed 1963-2001. Clinical details and cause of death were based on medical records. Mortality was 12-fold that of the general population, with 51.3 additional deaths per 10,000 person-years (21.9 yrs median follow-up). Cumulative mortality 15 yrs post-diagnosis was 6.9%, predominantly from late recurrences; thereafter the absolute contribution of other health outcomes increased. Cumulative all-cause and recurrence-related mortality were highest for Central Nervous System and bone tumor survivors. All-cause, but not subsequent tumor and circulatory disease-related cumulative mortality, was highest for patients diagnosed 1963-1979 vs. later (p-trend <0.001).

Keywords: Childhood cancer survivors; late mortality.

Publication types

  • Multicenter Study

MeSH terms

  • Bone Neoplasms / mortality
  • Cancer Survivors*
  • Cause of Death
  • Child
  • Cohort Studies
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / epidemiology
  • Neoplasms* / mortality
  • Neoplasms* / therapy
  • Netherlands / epidemiology